MENU
VIR
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Vir Biotechnology (VIR) Earnings Date & Reports
Vir Biotechnology Inc is a clinical-stage biopharmaceutical company focused on powering the immune system by discovering and developing medicines for serious infectious diseases and cancer... Show more
A.I. Advisor
published Earnings
VIR is expected to report earnings to fall 139.25% to 33 cents per share on July 30
Q2'26
Est.
$0.33
Q1'26
Missed
by $0.75
Q4'25
Beat
by $0.23
Q3'25
Missed
by $0.33
Q2'25
Missed
by $0.10
The last earnings report on May 06 showed earnings per share of -85 cents, missing the estimate of -10 cents. With 2.53M shares outstanding, the current market capitalization sits at 1.71B.
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information
General Information
a clinical-stage immunology company that focuses on combining immunologic insights with cutting-edge technologies to treat and prevent serious infectious diseases
Industry Biotechnology
Profile
Details
Industry
N/A
Address
1800 Owens Street
Phone
+1 415 906-4324
Employees
587
Web
https://www.vir.bio